Clinical trial
Subcutaneous Implantable Cardioverter Defibrillator (S-ICD®) System Post Approval Study
NCT01736618 is registered in ClinicalTrials.gov with Boston Scientific Corporation as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- Subcutaneous Implantable Cardioverter Defibrillator (S-ICD®) System Post Approval Study
- Lead sponsor
- Boston Scientific Corporation
- Phase
- Observational
- Overall status
- Completed
- Start date
- March 12, 2013
- Completion date
- October 15, 2021
- Enrollment
- 1,766 (actual)
- Sites
- 87
Conditions
As the registry lists them; a condition with its own page is linked.
primary prevention of sudden cardiac arrest, secondary prevention of sudden cardiac arrest